nodes	percent_of_prediction	percent_of_DWPC	metapath
Telmisartan—AGTR1—nephron—nephrolithiasis	0.0571	0.232	CbGeAlD
Telmisartan—PPARG—nephron—nephrolithiasis	0.0469	0.191	CbGeAlD
Telmisartan—CYP2C19—urine—nephrolithiasis	0.0284	0.116	CbGeAlD
Telmisartan—Losartan—SLC2A9—nephrolithiasis	0.0257	0.54	CrCbGaD
Telmisartan—Leg pain—Hydrochlorothiazide—nephrolithiasis	0.0228	0.0367	CcSEcCtD
Telmisartan—Losartan—SLC22A12—nephrolithiasis	0.0218	0.46	CrCbGaD
Telmisartan—Toothache—Hydrochlorothiazide—nephrolithiasis	0.0173	0.0279	CcSEcCtD
Telmisartan—Blood creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.0153	0.0246	CcSEcCtD
Telmisartan—AGTR1—nephron tubule—nephrolithiasis	0.0123	0.0501	CbGeAlD
Telmisartan—Rhabdomyolysis—Hydrochlorothiazide—nephrolithiasis	0.0119	0.0192	CcSEcCtD
Telmisartan—Gastrooesophageal reflux disease—Hydrochlorothiazide—nephrolithiasis	0.0117	0.0188	CcSEcCtD
Telmisartan—Hyperuricaemia—Hydrochlorothiazide—nephrolithiasis	0.0114	0.0183	CcSEcCtD
Telmisartan—Gout—Hydrochlorothiazide—nephrolithiasis	0.0113	0.0182	CcSEcCtD
Telmisartan—AGTR1—renal system—nephrolithiasis	0.0112	0.0455	CbGeAlD
Telmisartan—Hypercholesterolaemia—Hydrochlorothiazide—nephrolithiasis	0.0111	0.0179	CcSEcCtD
Telmisartan—AGTR1—kidney—nephrolithiasis	0.0108	0.044	CbGeAlD
Telmisartan—Blood uric acid increased—Hydrochlorothiazide—nephrolithiasis	0.0107	0.0173	CcSEcCtD
Telmisartan—AGTR1—cortex of kidney—nephrolithiasis	0.0105	0.0429	CbGeAlD
Telmisartan—Hyperkalaemia—Hydrochlorothiazide—nephrolithiasis	0.0104	0.0167	CcSEcCtD
Telmisartan—PPARG—renal system—nephrolithiasis	0.00921	0.0374	CbGeAlD
Telmisartan—ABCC2—nephron tubule—nephrolithiasis	0.0089	0.0362	CbGeAlD
Telmisartan—PPARG—kidney—nephrolithiasis	0.0089	0.0362	CbGeAlD
Telmisartan—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.00879	0.0141	CcSEcCtD
Telmisartan—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.00863	0.0139	CcSEcCtD
Telmisartan—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.00855	0.0138	CcSEcCtD
Telmisartan—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.00814	0.0131	CcSEcCtD
Telmisartan—ABCC2—renal system—nephrolithiasis	0.00809	0.0329	CbGeAlD
Telmisartan—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.00807	0.013	CcSEcCtD
Telmisartan—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.00807	0.013	CcSEcCtD
Telmisartan—Renal impairment—Hydrochlorothiazide—nephrolithiasis	0.00804	0.0129	CcSEcCtD
Telmisartan—Purpura—Hydrochlorothiazide—nephrolithiasis	0.00793	0.0128	CcSEcCtD
Telmisartan—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.00787	0.0127	CcSEcCtD
Telmisartan—ABCC2—kidney—nephrolithiasis	0.00783	0.0318	CbGeAlD
Telmisartan—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.00765	0.0123	CcSEcCtD
Telmisartan—ABCC2—cortex of kidney—nephrolithiasis	0.00762	0.031	CbGeAlD
Telmisartan—Migraine—Hydrochlorothiazide—nephrolithiasis	0.00753	0.0121	CcSEcCtD
Telmisartan—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.00738	0.0119	CcSEcCtD
Telmisartan—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.00716	0.0115	CcSEcCtD
Telmisartan—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.00701	0.0113	CcSEcCtD
Telmisartan—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.00699	0.0112	CcSEcCtD
Telmisartan—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.00696	0.0112	CcSEcCtD
Telmisartan—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.00691	0.0111	CcSEcCtD
Telmisartan—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.00689	0.0111	CcSEcCtD
Telmisartan—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.00677	0.0109	CcSEcCtD
Telmisartan—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.00675	0.0109	CcSEcCtD
Telmisartan—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.00665	0.0107	CcSEcCtD
Telmisartan—ABCG2—nephron tubule—nephrolithiasis	0.00649	0.0264	CbGeAlD
Telmisartan—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.00644	0.0104	CcSEcCtD
Telmisartan—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.00618	0.00994	CcSEcCtD
Telmisartan—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.00614	0.00988	CcSEcCtD
Telmisartan—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00611	0.00982	CcSEcCtD
Telmisartan—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00609	0.00979	CcSEcCtD
Telmisartan—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00593	0.00954	CcSEcCtD
Telmisartan—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.00581	0.00935	CcSEcCtD
Telmisartan—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.00579	0.00932	CcSEcCtD
Telmisartan—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.00578	0.00929	CcSEcCtD
Telmisartan—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00578	0.00929	CcSEcCtD
Telmisartan—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00573	0.00922	CcSEcCtD
Telmisartan—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00573	0.00922	CcSEcCtD
Telmisartan—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00562	0.00904	CcSEcCtD
Telmisartan—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00556	0.00894	CcSEcCtD
Telmisartan—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00553	0.0089	CcSEcCtD
Telmisartan—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00539	0.00867	CcSEcCtD
Telmisartan—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.0053	0.00853	CcSEcCtD
Telmisartan—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00526	0.00847	CcSEcCtD
Telmisartan—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00525	0.00845	CcSEcCtD
Telmisartan—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00521	0.00839	CcSEcCtD
Telmisartan—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.0051	0.0082	CcSEcCtD
Telmisartan—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00493	0.00794	CcSEcCtD
Telmisartan—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00491	0.0079	CcSEcCtD
Telmisartan—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00473	0.0076	CcSEcCtD
Telmisartan—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00461	0.00741	CcSEcCtD
Telmisartan—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00454	0.0073	CcSEcCtD
Telmisartan—Tension—Hydrochlorothiazide—nephrolithiasis	0.00452	0.00727	CcSEcCtD
Telmisartan—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00451	0.00726	CcSEcCtD
Telmisartan—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00447	0.0072	CcSEcCtD
Telmisartan—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00446	0.00717	CcSEcCtD
Telmisartan—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00443	0.00712	CcSEcCtD
Telmisartan—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00427	0.00687	CcSEcCtD
Telmisartan—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00426	0.00685	CcSEcCtD
Telmisartan—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00421	0.00677	CcSEcCtD
Telmisartan—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00415	0.00668	CcSEcCtD
Telmisartan—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00414	0.00666	CcSEcCtD
Telmisartan—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00413	0.00664	CcSEcCtD
Telmisartan—ABCG2—Iron uptake and transport—ATP6V0A4—nephrolithiasis	0.0041	0.0484	CbGpPWpGaD
Telmisartan—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00407	0.00655	CcSEcCtD
Telmisartan—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00405	0.00651	CcSEcCtD
Telmisartan—Cough—Hydrochlorothiazide—nephrolithiasis	0.00402	0.00647	CcSEcCtD
Telmisartan—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00392	0.00631	CcSEcCtD
Telmisartan—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00392	0.00631	CcSEcCtD
Telmisartan—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00392	0.00631	CcSEcCtD
Telmisartan—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00391	0.00629	CcSEcCtD
Telmisartan—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00387	0.00623	CcSEcCtD
Telmisartan—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00383	0.00617	CcSEcCtD
Telmisartan—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00376	0.00605	CcSEcCtD
Telmisartan—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00376	0.00605	CcSEcCtD
Telmisartan—Shock—Hydrochlorothiazide—nephrolithiasis	0.0037	0.00595	CcSEcCtD
Telmisartan—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00368	0.00592	CcSEcCtD
Telmisartan—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00367	0.0059	CcSEcCtD
Telmisartan—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00363	0.00585	CcSEcCtD
Telmisartan—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00358	0.00576	CcSEcCtD
Telmisartan—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00351	0.00565	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00342	0.00551	CcSEcCtD
Telmisartan—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.0034	0.00547	CcSEcCtD
Telmisartan—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00338	0.00543	CcSEcCtD
Telmisartan—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00335	0.00539	CcSEcCtD
Telmisartan—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00334	0.00538	CcSEcCtD
Telmisartan—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00331	0.00532	CcSEcCtD
Telmisartan—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00327	0.00526	CcSEcCtD
Telmisartan—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00324	0.00521	CcSEcCtD
Telmisartan—Pain—Hydrochlorothiazide—nephrolithiasis	0.00321	0.00517	CcSEcCtD
Telmisartan—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00321	0.00517	CcSEcCtD
Telmisartan—ABCB1—nephron tubule—nephrolithiasis	0.0032	0.013	CbGeAlD
Telmisartan—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.0031	0.00498	CcSEcCtD
Telmisartan—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00307	0.00495	CcSEcCtD
Telmisartan—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00299	0.0048	CcSEcCtD
Telmisartan—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00297	0.00478	CcSEcCtD
Telmisartan—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00297	0.00478	CcSEcCtD
Telmisartan—ABCB1—renal system—nephrolithiasis	0.00291	0.0118	CbGeAlD
Telmisartan—ABCB1—kidney—nephrolithiasis	0.00281	0.0114	CbGeAlD
Telmisartan—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00277	0.00446	CcSEcCtD
Telmisartan—ABCB1—cortex of kidney—nephrolithiasis	0.00274	0.0111	CbGeAlD
Telmisartan—SLCO1B3—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00272	0.0321	CbGpPWpGaD
Telmisartan—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.0027	0.00434	CcSEcCtD
Telmisartan—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00266	0.00428	CcSEcCtD
Telmisartan—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00257	0.00414	CcSEcCtD
Telmisartan—SLCO1B3—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00249	0.0293	CbGpPWpGaD
Telmisartan—SLCO1B3—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00249	0.0293	CbGpPWpGaD
Telmisartan—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00249	0.004	CcSEcCtD
Telmisartan—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00239	0.00384	CcSEcCtD
Telmisartan—Rash—Hydrochlorothiazide—nephrolithiasis	0.00237	0.00381	CcSEcCtD
Telmisartan—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00237	0.00381	CcSEcCtD
Telmisartan—Headache—Hydrochlorothiazide—nephrolithiasis	0.00235	0.00379	CcSEcCtD
Telmisartan—AGTR1—G alpha (q) signalling events—DGKH—nephrolithiasis	0.00233	0.0275	CbGpPWpGaD
Telmisartan—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00223	0.00359	CcSEcCtD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00209	0.0246	CbGpPWpGaD
Telmisartan—ABCC2—NRF2 pathway—SLC2A9—nephrolithiasis	0.00199	0.0235	CbGpPWpGaD
Telmisartan—SLCO1B3—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00189	0.0222	CbGpPWpGaD
Telmisartan—SLCO1B3—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00189	0.0222	CbGpPWpGaD
Telmisartan—SLCO1B3—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00175	0.0207	CbGpPWpGaD
Telmisartan—SLCO1B3—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00175	0.0207	CbGpPWpGaD
Telmisartan—AGTR1—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00169	0.0199	CbGpPWpGaD
Telmisartan—SLCO1B3—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00156	0.0184	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00155	0.0183	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00155	0.0183	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00151	0.0178	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00138	0.0163	CbGpPWpGaD
Telmisartan—AGTR1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.0013	0.0154	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00127	0.0149	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00127	0.0149	CbGpPWpGaD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00112	0.0132	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00111	0.0131	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00111	0.0131	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00099	0.0117	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—RGS14—nephrolithiasis	0.000984	0.0116	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000966	0.0114	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000966	0.0114	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000959	0.0113	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000959	0.0113	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000905	0.0107	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000905	0.0107	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—RGS14—nephrolithiasis	0.000894	0.0105	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000891	0.0105	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000891	0.0105	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000861	0.0101	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—CHRM3—nephrolithiasis	0.00085	0.01	CbGpPWpGaD
Telmisartan—CYP2C19—Biological oxidations—SLC26A1—nephrolithiasis	0.000841	0.00992	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000795	0.00936	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000795	0.00936	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000787	0.00928	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000787	0.00928	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—PTH—nephrolithiasis	0.000778	0.00917	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000686	0.00808	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000686	0.00808	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—DGKH—nephrolithiasis	0.000665	0.00783	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000638	0.00752	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000638	0.00752	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000635	0.00749	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—ADCY10—nephrolithiasis	0.000621	0.00732	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—DGKH—nephrolithiasis	0.000604	0.00711	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000597	0.00703	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000597	0.00703	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000568	0.0067	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000568	0.0067	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000555	0.00654	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000555	0.00654	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—GRHPR—nephrolithiasis	0.000551	0.00649	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—RGS14—nephrolithiasis	0.000528	0.00622	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000522	0.00615	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000522	0.00615	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000494	0.00583	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000494	0.00583	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—AGXT—nephrolithiasis	0.000491	0.00579	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000481	0.00566	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GRHPR—nephrolithiasis	0.00047	0.00554	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000465	0.00548	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000454	0.00536	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—PTH—nephrolithiasis	0.00044	0.00518	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—CHRM3—nephrolithiasis	0.000436	0.00514	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000426	0.00502	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000426	0.00502	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—AGXT—nephrolithiasis	0.000419	0.00494	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—APRT—nephrolithiasis	0.000418	0.00492	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—SLC26A1—nephrolithiasis	0.000418	0.00492	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—PTH—nephrolithiasis	0.000399	0.0047	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000395	0.00466	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—DGKH—nephrolithiasis	0.000357	0.0042	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000357	0.0042	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—SLC26A1—nephrolithiasis	0.000356	0.0042	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—APRT—nephrolithiasis	0.000356	0.0042	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GRHPR—nephrolithiasis	0.000343	0.00404	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000323	0.0038	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000323	0.0038	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—AGXT—nephrolithiasis	0.000305	0.0036	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.0003	0.00353	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.0003	0.00353	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—AQP1—nephrolithiasis	0.000297	0.00351	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CHRM3—nephrolithiasis	0.000269	0.00317	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000267	0.00315	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000267	0.00315	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—APRT—nephrolithiasis	0.00026	0.00306	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—SLC26A1—nephrolithiasis	0.00026	0.00306	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CHRM3—nephrolithiasis	0.000258	0.00304	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—AQP1—nephrolithiasis	0.000254	0.00299	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PTH—nephrolithiasis	0.000236	0.00278	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CHRM3—nephrolithiasis	0.00023	0.00271	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000214	0.00252	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GRHPR—nephrolithiasis	0.00019	0.00224	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GRHPR—nephrolithiasis	0.000185	0.00218	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—AQP1—nephrolithiasis	0.000185	0.00218	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—AGXT—nephrolithiasis	0.000169	0.00199	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CHRM3—nephrolithiasis	0.000167	0.00197	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—AGXT—nephrolithiasis	0.000165	0.00195	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—SLC26A1—nephrolithiasis	0.000144	0.0017	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—APRT—nephrolithiasis	0.000144	0.0017	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—APRT—nephrolithiasis	0.00014	0.00166	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—SLC26A1—nephrolithiasis	0.00014	0.00166	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—SPP1—nephrolithiasis	0.000118	0.0014	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—AQP1—nephrolithiasis	0.000103	0.00121	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—AQP1—nephrolithiasis	0.0001	0.00118	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CHRM3—nephrolithiasis	9.27e-05	0.00109	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CHRM3—nephrolithiasis	9.05e-05	0.00107	CbGpPWpGaD
